Rongrong Li

Rongrong Li

Auto-generated profile, based on publicly available information

Rongrong Li

Department of Neurology, Jinling Hospital, Medical School of Nanjing University, China.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
RLRongrong Li
Rongrong Li
JWJun Wang
Jun Wang
XYXiaoya Yu
Xiaoya Yu
PXPengfei Xu
Pengfei Xu
SZShuai Zhang
Shuai Zhang
GXGelin Xu
Gelin Xu
Transcranial magnetic stimulation (TMS) is a non-invasive and clinically approved method for treating neurological disorders. However, the relatively weak intracranial electric current induced by TMS is an obvious inferiority which can only produce limited treatment effects in clinical application. The present study aimed to investigate the possibility of enhancing the effects of TMS with intravenously administrated magnetic nanoparticles. To facilitate crossing of the blood–brain barrier (BBB), the superparamagnetic iron oxide nanoparticles (SPIONs) were coated with carboxylated chitosan and poly(ethylene glycol). To aid the nanoparticles in crossing the BBB and targeting the predesigned brain regions, an external permanent magnet was attached to the foreheads of the rats before the intravenous administration of SPIONs. The electrophysiological tests showed that the maximum MEP amplitude recorded in an individual rat was significantly higher in the SPIONs + magnet group than in the saline group (5.78 ± 2.54 vs. 1.80 ± 1.55 mV, P = 0.015). In the M1 region, biochemical tests detected that the number density of c-fos positive cells in the SPIONs + magnet group was 3.44 fold that of the saline group. These results suggest that intravenously injected SPIONs can enhance the effects of TMS in treating neurological disorders.

13 January 2019 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
PDF file
RLRongrong Li
Rongrong Li
ZDZhengze Dai
Zhengze Dai
RYRuidong Ye
Ruidong Ye
XLXinfeng Liu
Xinfeng Liu
ZXZhengkun Xia
Zhengkun Xia
GXGelin Xu
Gelin Xu
Previously, we reported that magnetic stimulation of carotid sinus (MSCS) could lower arterial pressure in rabbits. In this randomized, sham‐controlled pilot study, we evaluated the effects of MSCS on blood pressure in pre‐hypertensive and hypertensive subjects. A total of 15 subjects with blood pressure higher than 130/80 mm Hg were randomized to receive sham or 1Hz MSCS. The changes of systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MAP) during treatment were compared between groups. The heart rate variability (HRV) and baroreflex sensitivity (BRS) before, during, and after treatments were analyzed. Reduction of SBP was significantly greater in subjects with MSCS than those with sham stimulation (6.6 ± 0.4 vs −2.5 ± 0.4 mm Hg, P < 0.001). Reduction of DBP was significantly greater in subjects with MSCS than those with sham stimulation (1.2 ± 0.2 vs −2.8 ± 0.2 mm Hg, P < 0.001). Reduction of MAP was significantly greater in subjects with MSCS than those with sham stimulation (1.4 ± 0.3 mm Hg vs −4.0 ± 0.3 mm Hg, P < 0.001). Reduction of HR was significantly greater in subjects with MSCS than those with sham stimulation (0.5 ± 0.5 vs −1.9 ± 0.3 beats/min, P = 0.002). BRS increased from 6.85 ± 0.77 to 8.79 ± 0.95 ms/mm Hg after MSCS compared with that at baseline (P = 0.027). Thus, MSCS can lower blood pressure and heart rate in pre‐hypertensive and hypertensive subject, warranting further study for establishing MSCS as a treatment for hypertension.

16 November 2016 in Biomedicine Hub
Verified
Journal Article
Open access
PDF file
LNLizhi Niu
Lizhi Niu
XLXiaomei Luo
Xiaomei Luo
JZJianying Zeng
Jianying Zeng
XKXiaofeng Kong
Xiaofeng Kong
GFGang Fang
Gang Fang
KXKecheng Xu
Kecheng Xu
Objectives: A 36-year-old Asian man was referred to our hospital with cardiac metastasis. He had a history of alveolar soft part sarcoma and initially underwent resection in 2005. Methods: After exposing the tumor by thoracotomy, cryoablation was performed under ultrasound guidance. This treatment was combined with iodine-125 seed implantation to treat the cardiac metastasis. Results: The patient had an uneventful recovery, and his cardiac function shows no obvious abnormalities. Imaging techniques suggest that cardiac metastasis was well controlled, and the patient is still alive 12 months after treatment. Conclusions: Tumor cryoablation, combined with iodine seed implantations, may be regarded as a means of palliative treatment.

1 November 2012 in Livestock Science
Verified
Journal Article
Closed access
MYMa Yun
Ma Yun
NCNingbo Chen
Ningbo Chen
RLRongrong Li
Rongrong Li
TYTing Yang
Ting Yang
YXYongjie Xu
Yongjie Xu
JLJunya Li
Junya Li

23 March 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
XLXinxin Liu
Xinxin Liu
ZHZhengfei Hong
Zhengfei Hong
RLRongrong Li
Rongrong Li
SHShuxian Hou
Shuxian Hou
XSXuechao Shi
Xuechao Shi
JWJun Wang
Jun Wang

26 March 2026 in Tungsten
Verified
Journal Article
Closed access
JWJun Wang
Jun Wang
SWShui-Xia Wan
Shui-Xia Wan
RDRong-Rong Du
Rong-Rong Du
SHShu-Xian Hou
Shu-Xian Hou
YXYao Xiao
Yao Xiao
FYFu Yang
Fu Yang